Vivos Therapeutics Inc (VVOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,751 | -21,230 | -14,276 | -8,877 | -3,864 |
| Depreciation Amortization | 454 | 1,309 | 867 | 483 | 177 |
| Accounts receivable | -188 | -217 | -770 | -269 | -288 |
| Accounts payable and accrued liabilities | 318 | 524 | 948 | 608 | 109 |
| Other Working Capital | 482 | 3,997 | 1,244 | 445 | -426 |
| Other Operating Activity | 675 | 354 | 536 | 320 | 496 |
| Operating Cash Flow | $-6,010 | $-15,263 | $-11,451 | $-7,290 | $-3,796 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -18 | -2,341 | -810 | -893 | -122 |
| Net Acquisitions | N/A | -5,185 | -5,135 | -5,135 | N/A |
| Investing Cash Flow | $-18 | $-7,526 | $-5,945 | $-6,028 | $-122 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,400 | 10,673 | N/A | N/A | N/A |
| Debt Issued | N/A | N/A | 9,225 | 9,642 | N/A |
| Debt Repayment | -420 | -28 | -114 | N/A | N/A |
| Common Stock Issued | 5,616 | 8,750 | 5,949 | 2,655 | N/A |
| Other Financing Activity | -487 | -837 | -837 | -837 | 0 |
| Financing Cash Flow | $6,109 | $18,558 | $14,223 | $11,460 | $N/A |
| Beginning Cash Position | 2,029 | 6,260 | 6,260 | 6,260 | 6,260 |
| End Cash Position | 2,110 | 2,029 | 3,087 | 4,402 | 2,342 |
| Net Cash Flow | $81 | $-4,231 | $-3,173 | $-1,858 | $-3,918 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,010 | -15,263 | -11,451 | -7,290 | -3,796 |
| Capital Expenditure | -18 | -2,341 | -810 | -893 | -122 |
| Free Cash Flow | -6,028 | -17,604 | -12,261 | -8,183 | -3,918 |